Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Breast ; 29: 90-5, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27476083

ABSTRACT

PURPOSE: To evaluate toxicity in breast cancer patients treated with anthracycline and taxane based chemotherapy and whole breast hypofractionated radiotherapy, and to identify the risk factors for toxicity. METHODS AND MATERIALS: 537 early breast cancer patients receiving hypofractionated radiotherapy after conservative surgery were enrolled from April 2009 to December 2014, in an Italian cancer institute. The dose was 42.4 Gy in 16 daily fractions, 2.65 Gy per fraction. The boost to the tumor bed was administered only in grade III breast cancer patients and in patients with close or positive margins. Acute and late toxicity were prospectively assessed during and after radiotherapy according to RTOG scale. The impact of patients clinical characteristics, performed treatments and dose inhomogeneities on the occurrence of an higher level of acute skin toxicity and late fibrosis has been evaluated by univariate and multivariate analysis. RESULTS: The mean age was 74 (range 46-91 yrs). 27% of patients received boost. 22% of cases (n = 119) received also chemotherapy. The median follow-up was 32 months. G1 and G2/G3 acute skin toxicity were 61.3% and 20.5% and G1 and G2/G3 late fibrosis 12.6% and 4.3% respectively. Chemotherapy (p = 0.04), diabetes (p = 0.04) and boost administration (p < 0.01) were found to be statistically significant on the occurrence of late fibrosis, but a multivariate analysis did not show any factors connected. The boost administration (p < 0.01), the breast volume (p = 0.05), dose inhomogeneities (p < 0.01) and boost volume (p = 0.04) were found to be statistically significant as concerns the occurrence of acute skin reaction at the univariate analysis, but only the boost administration (p = 0.02), at multivariate analysis. CONCLUSIONS: The results of our study, according to the large randomized trials, confirmed that hypofractionated whole breast irradiation is safe, and only the boost administration seems to be an important predictor for toxicity. Chemotherapy does not impact on acute and late skin toxicity.


Subject(s)
Antineoplastic Agents/adverse effects , Breast Neoplasms/therapy , Chemoradiotherapy, Adjuvant/adverse effects , Radiation Dose Hypofractionation , Radiation Injuries/etiology , Aged , Aged, 80 and over , Anthracyclines/adverse effects , Breast/pathology , Breast/radiation effects , Breast Neoplasms/pathology , Bridged-Ring Compounds/adverse effects , Dose-Response Relationship, Radiation , Female , Fibrosis , Follow-Up Studies , Humans , Middle Aged , Multivariate Analysis , Neoplasm Staging , Prospective Studies , Re-Irradiation/adverse effects , Risk Factors , Skin/radiation effects , Taxoids/adverse effects
2.
J Sports Med Phys Fitness ; 52(6): 616-21, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23187324

ABSTRACT

AIM: The aim of this paper was to report clinical, functional and radiological results of 80 patients surgically treated with a combined mini-open and percutaneous surgical repair as proposed by Kakiuchi. METHODS: All patients were evaluated with a physical examination, evaluation scales, a functional test (Ergo-jump Bosco System), and an ultrasonographic exam along with Power Doppler Ultrasonography (PDU) (S/S). RESULTS: At a mean follow-up of 58 months no cases of rerupture were detected. VISA-A evaluation scale showed an excellent score in 63 patients (78.75%), a good score in 14 patients (17.5%), a fair score in two patients (2.5%), and a poor score in one patient (1.25%). Hannover scale showed an excellent score in 63 patients (78.75%), and a good score in 17 patients (21.25%). Ergo-Jump evaluation showed a 2.07% mean deficit of the affected limb at the Squatting Jump test, a 3.26% mean deficit at the Counter Movement Jump test, and a 0.0062% mean improvement at the Repetitive Jump test. Ultrasonographic exam showed in all cases a satisfactory recovery of the integrity of the operated tendon. The mean AP and LL widths showed a significant increase of 7.13±2.97 mm (+56.1%) and of 4.01±2.36 mm (+43.81%) respectively. According to the modified Öhberg score scale, PDU exam showed a grade +1 in 16 patients (20%) and a grade +2 in seven cases (8.7%). CONCLUSION: The absence of rerupture cases, the satisfactory functional and ultrasonographic results of the patients included in this study cause us to consider this technique as reliable and effective even in young high-demand patients.


Subject(s)
Achilles Tendon/surgery , Ankle Injuries/physiopathology , Ankle Joint/physiopathology , Minimally Invasive Surgical Procedures/methods , Orthopedic Procedures/methods , Tendon Injuries/diagnostic imaging , Ultrasonography, Doppler/methods , Achilles Tendon/diagnostic imaging , Adult , Ankle Injuries/diagnostic imaging , Ankle Joint/surgery , Female , Follow-Up Studies , Humans , Male , Range of Motion, Articular , Retrospective Studies , Rupture/physiopathology , Rupture/surgery , Tendon Injuries/physiopathology , Tendon Injuries/surgery , Treatment Outcome
3.
Int J Pharm ; 330(1-2): 183-94, 2007 Feb 07.
Article in English | MEDLINE | ID: mdl-17157460

ABSTRACT

Hydrophobic ([tetrakis(2,4-dimetil-3-pentyloxi)-phthalocyaninate]zinc(II)) (ZnPc) and hydrophilic ([tetrakis(N,N,N-trimethylammoniumetoxi)-phthalocyaninate]zinc(II) tetraiodide) (ZnPcMet) phthalocyanines were synthesized and loaded in ultradeformable liposomes (UDL) of soybean phosphatidylcholine and sodium cholate (6:1, w/w, ratio), resulting 100 nm mean size vesicles of negative Zeta potential, with encapsulation efficiencies of 85 and 53%, enthalpy of phase transition of 5.33 and 158 J/mmol for ZnPc and ZnPcMet, respectively, indicating their deep and moderate partition into UD matrices. Matrix elasticity of UDL-phthalocyanines resulted 28-fold greater than that of non-UDL, leaking only 25% of its inner aqueous content after passage through a nanoporous barrier versus 100% leakage for non-UDL. UDL-ZnPc made ZnPc soluble in aqueous buffer while kept the monomeric state, rendering singlet oxygen quantum yield (Phi(Delta)) similar to that obtained in ethanol (0.61), whereas UDL-ZnPcMet had a four-fold higher Phi(Delta) than that of free ZnPcMet (0.21). Free phthalocyanines were non-toxic at 1 and 10 microM, both in dark or upon irradiation at 15 J/cm2 on Vero and J-774 cells (MTT assay). Only liposomal ZnPc at 10 microM was toxic for J-774 cells under both conditions. Additionally, endo-lysosomal confinement of the HPTS dye was kept after irradiation at 15 J/cm2 in the presence of UDL-phtalocyanines. This could lead to improve effects of singlet oxygen against intra-vesicular pathogen targets inside the endo-lysosomal system.


Subject(s)
Indoles/chemistry , Liposomes/chemistry , Radiation-Sensitizing Agents/chemistry , Animals , Calorimetry, Differential Scanning , Cell Survival/drug effects , Chlorocebus aethiops , Indoles/administration & dosage , Indoles/chemical synthesis , Isoindoles , Leishmaniasis, Cutaneous/drug therapy , Liposomes/administration & dosage , Liposomes/chemical synthesis , Macrophages/drug effects , Macrophages/metabolism , Macrophages/radiation effects , Mice , Microscopy, Electron, Transmission , Nanotechnology , Photochemotherapy/methods , Radiation-Sensitizing Agents/administration & dosage , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...